For most healthy adults, NAD+ supplements are unlikely to deliver the dramatic anti-aging benefits that marketing materials promise. The science behind NAD+ is genuinely interesting, and there are real biological reasons to care about it, but the gap between what happens in lab studies and what’s been proven in humans remains wide. At $40 to $100 per month for oral supplements, that’s a meaningful investment for uncertain returns.
Here’s what we actually know, what’s still speculation, and how to decide if it makes sense for you.
What NAD+ Does in Your Body
NAD+ (nicotinamide adenine dinucleotide) is a molecule found in every cell. It plays a central role in converting food into energy and activating a family of proteins called sirtuins, which help regulate DNA repair, inflammation, and cellular stress responses. When DNA gets damaged, repair proteins consume NAD+ to fix it. Sirtuins also need NAD+ to function. So when NAD+ levels drop, both DNA repair and cellular maintenance slow down.
This creates a compelling theory: if falling NAD+ levels contribute to aging, then boosting those levels should slow the process. Animal studies have shown exactly that. Mice given NAD+ precursors showed improved mitochondrial function, better insulin sensitivity, and even reversed some markers of aging. The problem is that mice are not people, and the human evidence is far less impressive.
How Much NAD+ Declines With Age
The decline is real, but it’s more modest and more complicated than supplement companies suggest. A study published in Frontiers in Endocrinology measured whole blood NAD+ across age groups and found that levels drop meaningfully in men after age 60. Men in their 60s and beyond had significantly lower NAD+ than men under 30. But in women, NAD+ levels didn’t significantly differ across age groups at all.
This sex-based difference is rarely mentioned in supplement marketing, which tends to present NAD+ decline as universal and dramatic. The reality is more nuanced. NAD+ does decrease with age, but the rate and significance vary by sex, tissue type, and individual health status.
What Human Studies Actually Show
The human evidence for NAD+ supplementation is, to put it plainly, underwhelming so far. Oral precursors like NR and NMN do raise blood levels of NAD+. That part works. The question is whether higher blood levels translate into benefits you can feel or measure.
A double-blind trial testing NAD+ supplementation on cognitive function in 37 women over 28 days found improvements across measures of executive function, working memory, and processing speed. But the placebo group improved by nearly the same amount. After adjusting for baseline scores, there was no significant difference between the NAD+ group and placebo. In other words, the supplement didn’t outperform a sugar pill for brain function.
Research on metabolic health has been similarly mixed. Some studies found that boosting NAD+ pathways improved skeletal muscle energy production and mitochondrial function in people with type 2 diabetes. But those same benefits didn’t show up in obese individuals without diabetes when researchers used more precise measurement techniques. The effects seem to depend heavily on who’s taking the supplement and what’s already going wrong in their metabolism.
Several clinical trials are still underway testing NMN for exercise tolerance in older adults, measuring outcomes like time to fatigue during cycling, peak oxygen consumption, and lactate threshold. These are well-designed studies, but results aren’t in yet. The honest answer right now is that we’re still waiting for the kind of large, rigorous human trials that would justify confident recommendations.
Oral Supplements vs. IV Therapy
You can’t actually take NAD+ itself as a pill. The molecule is too large to survive digestion and absorption intact. Instead, oral supplements contain precursors, primarily NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide), which your body then converts into NAD+ through its own biochemical pathways.
The catch is bioavailability. Any oral supplement has to survive stomach acid, get absorbed through the small intestine, and pass through the liver before reaching general circulation. A significant portion gets broken down along the way. How much actually reaches your cells in usable form is an open question that varies by formulation, and no supplement company has definitive absorption data in humans.
IV therapy, which typically costs $250 to $1,000 per session, delivers NAD+ directly into the bloodstream and bypasses the digestive system entirely. Clinics promote this as a major advantage. But there are no published clinical trials comparing IV NAD+ to oral precursors head-to-head in a rigorous way. The higher price tag doesn’t come with proportionally better evidence.
Safety Concerns Worth Knowing
NAD+ precursors are generally considered safe at standard doses. The most common side effects are mild: nausea, stomach discomfort, headaches, lightheadedness, and diarrhea. Supplements containing niacin (nicotinic acid) can cause flushing, a temporary warmth and redness in the skin. At high doses, niacin-based forms can cause liver toxicity.
There’s one concern that deserves attention even though it remains theoretical. Cancer cells are energy-hungry, and NAD+ plays a key role in cellular energy production. Some researchers worry that flooding the body with NAD+ precursors could inadvertently support the growth of existing cancer cells. This hasn’t been proven in humans, but it hasn’t been ruled out either. People with a history of cancer should take this seriously.
The bigger safety gap is simply time. We don’t have long-term safety data for most NAD+ supplements. Most human trials lasted weeks to a few months. If you’re considering taking these supplements for years, as the anti-aging pitch implies you should, you’re essentially volunteering for an uncontrolled long-term experiment.
The Regulatory Landscape
NMN had a rocky few years legally. In November 2022, the FDA classified it as an investigational new drug, which effectively barred it from being sold as a dietary supplement. Companies kept selling it anyway in a gray market. In September 2025, the FDA reversed that position and confirmed NMN can be lawfully marketed as a dietary supplement. It now moves through the standard New Dietary Ingredient notification framework.
This regulatory reversal means NMN is easier to find and buy, but it doesn’t mean the FDA has evaluated it for effectiveness. Dietary supplements don’t require proof that they work before reaching store shelves. NR (nicotinamide riboside) has been available as a supplement throughout this period without the same regulatory complications.
What You’re Really Paying For
Oral NAD+ precursors run $40 to $100 per month, or roughly $480 to $1,200 per year. For that money, you’re getting a supplement that reliably raises blood NAD+ levels but has not yet been shown to produce consistent, clinically meaningful benefits in healthy humans. The theoretical foundation is strong. The animal data is promising. The human proof is thin.
If you’re already eating well, exercising regularly, sleeping enough, and managing stress, NAD+ supplements are unlikely to add a noticeable layer of benefit based on current evidence. Exercise itself is one of the most effective ways to maintain NAD+ levels and activate the same sirtuin pathways that supplements target. If you’re not doing those basics, your money is better spent there first.
For people with specific metabolic conditions, particularly type 2 diabetes, there are early signals that NAD+ pathway support could improve mitochondrial function in skeletal muscle. But even here, the results are inconsistent and the studies are small. NAD+ supplementation sits in a category that’s familiar in the supplement world: biologically plausible, supported by animal research, promoted aggressively, and not yet validated in the people actually buying it.